316 related articles for article (PubMed ID: 17244320)
1. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
3. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
Nakamura S; Nambu M; Ishizuka T; Hattori H; Kanatani Y; Takase B; Kishimoto S; Amano Y; Aoki H; Kiyosawa T; Ishihara M; Maehara T
J Biomed Mater Res A; 2008 Jun; 85(3):619-27. PubMed ID: 17806115
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2.
Obara K; Ishihara M; Fujita M; Kanatani Y; Hattori H; Matsui T; Takase B; Ozeki Y; Nakamura S; Ishizuka T; Tominaga S; Hiroi S; Kawai T; Maehara T
Wound Repair Regen; 2005; 13(4):390-7. PubMed ID: 16008728
[TBL] [Abstract][Full Text] [Related]
6. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel.
Fujita M; Ishihara M; Simizu M; Obara K; Ishizuka T; Saito Y; Yura H; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
Biomaterials; 2004 Feb; 25(4):699-706. PubMed ID: 14607508
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction.
Fujita M; Ishihara M; Morimoto Y; Simizu M; Saito Y; Yura H; Matsui T; Takase B; Hattori H; Kanatani Y; Kikuchi M; Maehara T
J Surg Res; 2005 Jun; 126(1):27-33. PubMed ID: 15916971
[TBL] [Abstract][Full Text] [Related]
8. The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation.
Masuoka K; Ishihara M; Asazuma T; Hattori H; Matsui T; Takase B; Kanatani Y; Fujita M; Saito Y; Yura H; Fujikawa K; Nemoto K
Biomaterials; 2005 Jun; 26(16):3277-84. PubMed ID: 15603823
[TBL] [Abstract][Full Text] [Related]
9. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth.
Ishihara M; Fujita M; Obara K; Hattori H; Nakamura S; Nambu M; Kiyosawa T; Kanatani Y; Takase B; Kikuchi M; Maehara T
Curr Drug Deliv; 2006 Oct; 3(4):351-8. PubMed ID: 17076636
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
Obara K; Ishihara M; Ozeki Y; Ishizuka T; Hayashi T; Nakamura S; Saito Y; Yura H; Matsui T; Hattori H; Takase B; Ishihara M; Kikuchi M; Maehara T
J Control Release; 2005 Dec; 110(1):79-89. PubMed ID: 16289419
[TBL] [Abstract][Full Text] [Related]
11. Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels.
Hosaka A; Koyama H; Kushibiki T; Tabata Y; Nishiyama N; Miyata T; Shigematsu H; Takato T; Nagawa H
Circulation; 2004 Nov; 110(21):3322-8. PubMed ID: 15520306
[TBL] [Abstract][Full Text] [Related]
12. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model.
Ruvinov E; Leor J; Cohen S
Biomaterials; 2010 Jun; 31(16):4573-82. PubMed ID: 20206988
[TBL] [Abstract][Full Text] [Related]
13. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
Matsui M; Tabata Y
Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
[TBL] [Abstract][Full Text] [Related]
14. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model.
Iwakura A; Fujita M; Kataoka K; Tambara K; Sakakibara Y; Komeda M; Tabata Y
Heart Vessels; 2003 May; 18(2):93-9. PubMed ID: 12756606
[TBL] [Abstract][Full Text] [Related]
15. Chitosan hydrogel as a drug delivery carrier to control angiogenesis.
Ishihara M; Obara K; Nakamura S; Fujita M; Masuoka K; Kanatani Y; Takase B; Hattori H; Morimoto Y; Ishihara M; Maehara T; Kikuchi M
J Artif Organs; 2006; 9(1):8-16. PubMed ID: 16614797
[TBL] [Abstract][Full Text] [Related]
16. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.
Horio T; Fujita M; Tanaka Y; Ishihara M; Kishimoto S; Nakamura S; Hase K; Maehara T
J Vasc Surg; 2011 Sep; 54(3):791-8. PubMed ID: 21620612
[TBL] [Abstract][Full Text] [Related]
18. Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice.
Obara K; Ishihara M; Ishizuka T; Fujita M; Ozeki Y; Maehara T; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
Biomaterials; 2003 Sep; 24(20):3437-44. PubMed ID: 12809772
[TBL] [Abstract][Full Text] [Related]
19. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
[TBL] [Abstract][Full Text] [Related]
20. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia.
Laham RJ; Rezaee M; Post M; Novicki D; Sellke FW; Pearlman JD; Simons M; Hung D
J Pharmacol Exp Ther; 2000 Feb; 292(2):795-802. PubMed ID: 10640320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
